Michael H. Beasley, MD (@mhbeasleymd) 's Twitter Profile
Michael H. Beasley, MD

@mhbeasleymd

@Mwavisu's Hubby & #GirlDad x 4 / @YaleMed @YaleCardiology @YaleHF Doc & Educator / Co-Host @HFSA #HFBeat Podcast

ID: 1038828851638558720

linkhttps://medicine.yale.edu/profile/michael_beasley/ calendar_today09-09-2018 16:37:53

1,1K Tweet

1,1K Takipçi

1,1K Takip Edilen

Yale Cardiology (@yalecardiology) 's Twitter Profile Photo

A new Yale outpatient palliative care clinic is now providing dedicated, coordinated care for people with end-stage heart failure. Read more: medicine.yale.edu/news-article/p… Michael H. Beasley, MD Nora Segar

HFSA (@hfsa) 's Twitter Profile Photo

"Palliative care isn’t just end-of-life—it’s about living better with heart failure," says Sarah Chuzi. The Get w/ the Guidelines #HFBeat episode dives into integrating primary and specialty #palliativecare into practice. 🩺 🎙 Listen now! hfsa.org/heart-failure-… Haider Warraich

"Palliative care isn’t just end-of-life—it’s about living better with heart failure," says <a href="/SarahChuzi/">Sarah Chuzi</a>. The Get w/ the Guidelines #HFBeat episode dives into integrating primary and specialty #palliativecare into practice. 🩺 🎙 Listen now! hfsa.org/heart-failure-… <a href="/haiderwarraich/">Haider Warraich</a>
Ramya Sampath, MD (@ramyasampathmd) 's Twitter Profile Photo

Getting pumped🫀for #acc25! Presenting my poster on heart failure and pall care clinicians' perspectives on pall care for LVAD patients. Michael H. Beasley, MD Yale Internal Medicine Yale Cardiology Yale Heart Failure #CardioTwitter who can I look forward to seeing soon? 🛫

HFSA (@hfsa) 's Twitter Profile Photo

Women with non-ischemic cardiomyopathy see greater benefit from CRT,’ says Ilan Goldenberg on the #HFBeat. Learn how sex-specific insights are shaping heart failure care. Listen now! 🎧 hfsa.org/heart-failure-… #Cardiology #HeartFailure Michael H. Beasley, MD Priya Umapathi Anu Lala-Trindade

Women with non-ischemic cardiomyopathy see greater benefit from CRT,’ says <a href="/IlanGoldenberg2/">Ilan Goldenberg</a> on the #HFBeat. Learn how sex-specific insights are shaping heart failure care. Listen now! 🎧 hfsa.org/heart-failure-… 

#Cardiology #HeartFailure <a href="/MHBeasleyMD/">Michael H. Beasley, MD</a> <a href="/priyaumapathi/">Priya Umapathi</a> <a href="/dranulala/">Anu Lala-Trindade</a>
Uri Goldberg, MD (@harmonypall) 's Twitter Profile Photo

New paper underscores the critical role of palliative care in heart failure—timely evidence as Yale Cardiology, Michael H. Beasley, MD launch a dedicated palliative HF clinic. The shift toward more holistic, patient-centered care is gaining momentum. cureus.com/articles/34519…

Michael H. Beasley, MD (@mhbeasleymd) 's Twitter Profile Photo

Dr. Ashley Hardin of UTSW Heart joins the #AHFTC lecture series to discuss all things #pulmonaryhypertension: risk assessment, treatment algorithms, vasoreactivity testing, and more!!! Yale Heart Failure Maryjane Farr MD MSc, FACC FAST FHFSA FAHA youtu.be/JQzL_0xBFZo?si…

Dr. Ashley Hardin of <a href="/utswheart/">UTSW Heart</a> joins the #AHFTC lecture series to discuss all things #pulmonaryhypertension: risk assessment, treatment algorithms, vasoreactivity testing, and more!!! <a href="/YaleHF/">Yale Heart Failure</a> <a href="/MaryjaneFarrMD/">Maryjane Farr MD MSc, FACC FAST FHFSA FAHA</a> 
youtu.be/JQzL_0xBFZo?si…
HFSA (@hfsa) 's Twitter Profile Photo

Are women with heart failure being underdiagnosed? Anu Lala-Trindade shares: ‘Women’s natriuretic peptide levels may lead to underdiagnoses, particularly in HFpEF.’ Dive into the latest HF Beat episode for actionable insights on sex-specific heart failure research. 🎧 Listen here:

Are women with heart failure being underdiagnosed? <a href="/dranulala/">Anu Lala-Trindade</a> shares: ‘Women’s natriuretic peptide levels may lead to underdiagnoses, particularly in HFpEF.’ Dive into the latest HF Beat episode for actionable insights on sex-specific heart failure research. 

🎧 Listen here:
Michael H. Beasley, MD (@mhbeasleymd) 's Twitter Profile Photo

I am excited to share this wonderful story about a clinic we've started at Yale New Haven Health that is dedicated to supporting our patients facing end-stage heart failure.Yale Cardiology Yale Heart Failure m.yale.edu/c43x

Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA with a top 10 list of cardiogenic shock takeaways post publishing of the ACC clinical pathway statement Rachna Kataria, MD Navin Kapur Must listen for FITs! Heart Failure Beat Podcast: Top 10 Takeaways from the Cardiogenic S... youtube.com/shorts/XUFhmqp… via YouTube

<a href="/ShashankSinhaMD/">Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA</a> with a top 10 list of cardiogenic shock takeaways post publishing of the ACC clinical pathway statement <a href="/rachkataria/">Rachna Kataria, MD</a> <a href="/NavinKapur4/">Navin Kapur</a> 

Must listen for FITs!

Heart Failure Beat Podcast: Top 10 Takeaways from the Cardiogenic S... youtube.com/shorts/XUFhmqp… via <a href="/YouTube/">YouTube</a>
HFSA (@hfsa) 's Twitter Profile Photo

"Reassess. Reassess. And when you’re done—reassess again." Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA joins hosts Michael H. Beasley, MD and Priya Umapathi to explain why time-sensitive, serial reassessment is the cornerstone of cardiogenic shock care. 📊 Listen to the full #HFBeat episode on the 2025 ACC shock

"Reassess. Reassess. And when you’re done—reassess again."

<a href="/ShashankSinhaMD/">Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA</a> joins hosts <a href="/MHBeasleyMD/">Michael H. Beasley, MD</a> and <a href="/priyaumapathi/">Priya Umapathi</a> to explain why time-sensitive, serial reassessment is the cornerstone of cardiogenic shock care.

📊 Listen to the full #HFBeat episode on the 2025 ACC shock
HFSA (@hfsa) 's Twitter Profile Photo

💡“Call early and call often.” In our latest #HFBeat episode, Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA joins hosts Michael H. Beasley, MD and Priya Umapathi to share 10 key takeaways from the 2025 ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock. From staging to shock teams

Michael H. Beasley, MD (@mhbeasleymd) 's Twitter Profile Photo

In this #AHFTC lecture series presentation, Dr. Ken Margulies provides a broad overview of the pathophysiological processes that drive the development of clinical heart failure. Yale Heart Failure Penn Cardiology youtu.be/ILU3Z8Y3tJo?si…

Michael H. Beasley, MD (@mhbeasleymd) 's Twitter Profile Photo

In this presentation, Stephanie Stocker explains how immunosuppressants work, their side effects, and possible drug interactions in heart transplant patients. #AHFTC Yale Heart Failure Yale New Haven Hosp YaleTransplant youtu.be/AURsjCdFfaE?si…

HFSA (@hfsa) 's Twitter Profile Photo

📋 What are the 10 things every clinician managing cardiogenic shock needs to remember? Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA breaks it down—from invasive hemodynamics to end-organ perfusion to team-based care. Listen to the latest #HFBeat podcast → 🔗 hfsa.org/heart-failure-… Michael H. Beasley, MD

Michael H. Beasley, MD (@mhbeasleymd) 's Twitter Profile Photo

"Good things take time, as they should. We shouldn’t expect good things to happen overnight. Actually, getting something too easily or too soon can cheapen the outcome." - John Wooden

HFSA (@hfsa) 's Twitter Profile Photo

A true multidisciplinary shock team isn’t optional—it’s essential. 🫁 ER 🫀 Interventional 🧠 Critical care 🩺 Heart failure ⚕️ Surgery & ECMO The latest #HFBeat shows how the best teams coordinate care in minutes. 🔗 hfsa.org/heart-failure-… Michael H. Beasley, MD Priya Umapathi

HFSA (@hfsa) 's Twitter Profile Photo

New Episode of HF Beat: Gene Therapy in Genetic Cardiomyopathies 🧬 "Gene therapy isn’t science fiction anymore—it's here. 'We saw hearts shrink 40% in mass and troponins drop by 90%,' says Eric Adler on his groundbreaking Danon disease trial. Listen to how gene therapy is

New Episode of HF Beat: Gene Therapy in Genetic Cardiomyopathies 🧬

"Gene therapy isn’t science fiction anymore—it's here. 'We saw hearts shrink 40% in mass and troponins drop by 90%,' says <a href="/EricAdler17/">Eric Adler</a> on his groundbreaking Danon disease trial. Listen to how gene therapy is